Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

General American Investors

Kayne Anderson MLP Investment

Neuberger Berman Next Generation Connectivity Fund

Royce Value Trust

As contrarians, we search for income stocks that vanilla investors hate. Today there are not many dividend deals left.

5 Cheap Dividend Funds Trading For Pennies On The Dollar

Apollo Tactical Income Fund, Inc.

Atlantica Sustainable Infrastructure

B2Gold

FS Credit Opportunities Corp

Ocugen, Inc.

Perion Network

Virtus InfraCap U.S. Preferred Stock ETF

B. Riley Financial

Rocket Lab USA

SurgePays

AT&T

AT&T 5.35 % Notes 2017-01.11.66 Global

Verizon

Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks that receive limited coverage across Seeking Alpha.

The 'Undercovered' Dozen From March 2024

Tekla Life Sciences Investors

Tekla Healthcare Opportunities

Tekla World Healthcare Fund

PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.

abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

Blue Owl Capital Corp

I can pay my bills in retirement with cash, and I get that cash from picks like these. Your retirement is going to cost you, so have a way to pay for it. Healthcare and Business Development Companies provide strong income to shareholders.

I Am Loading Up On 2 Bargain Fat Dividends

abrdn Healthcare Investors is a healthcare sector-specific closed-end fund that invests in a portfolio of common stocks in the healthcare industry, heavily weighted in biotechnology. The HQH CEF currently provides a very high yield of 11% plus a high discount of -15% to NAV. HQH has a solid long-term record of nearly 37 years, nearly matching the performance of the S&P 500. However, the recent near- and mid-term performance has been lackluster.

HQH: Healthcare Fund With 11% Income And A High Discount

Automatic Data Processing

Bristol-Myers

BlackRock Science & Technology

Crown Castle International

Calamos Convertible Opportunities And Income Fund

Deere & Company

Enbridge

SPDR Gold Trust

Mastercard

Main Street Capital

MPLX

Microsoft

Realty Income Corp

PIMCO Dynamic Income Fund

PepsiCo

Invesco QQQ

Cohen & Steers Reit And Preferred Income Fund Inc

iShares 20+ Year Treasury Bond ETF

Liberty All Star Equity Fund

Cohen & Steers Infrastructure Fund Inc

Reaves Utility Income Fund

Visa

The Near Perfect Portfolio Strategy provides SWAN-like attributes and aims to meet income and growth goals while minimizing volatility and drawdowns. The strategy consists of three buckets: Dividend Growth Investing, High Income (CEF investing), and Hedging (Rotational bucket). Backtesting results over 17 years show that the strategy has the potential to outperform the S&P 500, with lower drawdowns and volatility.

How To Invest In A SWAN Portfolio: The Near Perfect Portfolio Strategy

PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective distribution rate and announce payment details for the Funds in the chart directly below. Ticker Exchange Fund Distribution Policy Previous Distribution Policy New Declared Distribution Amount HQH NYSE abrdn Healthcare Investors Annualized rate of 8% of rolling NAV Annualized rate of 10% of rolling NAV $ 0.4800 HQL NYSE abrdn Life Sciences Investors Annualized rate of 8% of rolling NAV Annualized rate of 10% of rolling NAV $ 0.3900 THQ NYSE abrdn Healthcare Opportunities Fund $0.1125 per share per month $0.18 per share per month $ 0.1800 HQL and HQH each distribute quarterly, and THQ distributes monthly all or a portion of its net investment income, including current gains, to common shareholders.

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate

The abrdn Healthcare Investors (HQH) fund has a 36-year track record of underperforming peers that does not create confidence for future results. HQH focuses on mid and large-cap biotech and pharmaceutical companies in late-stage clinical trials i.e. FDA approval catalysts. Capital gains distribution requires reinvestment to achieve compounding returns.

HQH: Disappointing Track Record

Dynex Capital

The market is not efficient and it is driven by a few select names. I strongly believe that income is the answer to your expenses. True financial freedom is income overwhelming expenses.

I Am Bottom Fishing: 2 Great Dividends +9%

Ares Capital

Ares Dynamic Credit Allocation Fund

AllianceBernstein Global High Income Fund Inc

BlackRock Taxable Municipal Bond Trust

BlackRock Enhanced Equity Dividend Trust

Central Securities

DNP Select Income Fund Inc

Eaton Vance Enhanced Equity Income Fund II

Energy Transfer LP Unit

Flaherty & Crumrine Preferred Securities Income Fund Inc

Guggenheim Strategic Opportunities Fund

New American High Income Fund

India Fund Inc

Barings Corporate Investors

Annaly Capital

Nuveen Municipal High Income Opportunity Fund

John Hancock Premium Dividend Fund

Cohen And Steers Total Return Realty Fund

2023 year-end review of our 8% Income Portfolio. This high-income portfolio earned over $29,000 in distributions amounting to over 14% yield-on-cost basis and roughly 8.6% on average portfolio value. We will provide updates on trades during the year, dividends collected, and overall performance. As usual, we will compare the performance with a traditional 60:40 stock/bond portfolio.

The 8% Income Portfolio: 2023 Year-End Review

BlackRock Health Sciences Trust II

Saba Capital Income & Opportunities Fund

Blackrock Floating Rate Income Strategies Fund Inc

Nuveen AMT-Free Municipal Value Fund

OFS Credit Company Inc

Invesco S&P 500 Equal Weight ETF

Special Opportunities Fund Inc

SPDR S&P 500 ETF Trust

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

Equity and fixed-income markets had another strong month in December, driven by continuing retreating risk-free Treasury rates. We even saw an improvement in the breadth of the overall market, with broader participation lifting some of the beaten-down sectors for the year. That said, closed-end fund discounts remain historically wide, and that continues to drive opportunity in the CEF wrapper.

5 Closed-End Fund Buys In The Month Of December 2023 (Plus 1 Sell)

Virtus Artificial Intelligence & Technology Opportunities Fund

Global X Artificial Intelligence & Technology ETF

ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Oil & Gas

Eaton Vance Enhanced Equity Income Fund

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

iShares Nasdaq Biotechnology ETF

Intel

iShares Russell 2000 ETF

NVIDIA

Novo Nordisk

First Trust Cloud Computing ETF

ProShares Ultra S&P 500

Energy Select Sector SPDR Fund

Exxon Mobil

In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding factor for why so few stocks, think Magnificent 7, received the lion's share of buy-interest while most everything else suffered, including equity CEFs. But just because the Federal Reserve will continue its Quantitative Tapering doesn't mean that other Fed programs won't increase liquidity in other places.

Equity CEFs/ETFs: Top Picks For 2024 - Part II

abrdn Healthcare Investors continues to face pressure as healthcare and biotech sectors remain out of favor. HQH remains an attractive buy if one believes that the healthcare and biotech space can rebound in time and also offers a significant discount. HQH offers an attractive distribution while waiting for the sector to turn around to more favorable times.

HQH: Remains Beaten Down But Also Remains An Interesting Prospect

How's the colder weather treating you? Fighting a cold? I get paid by the healthcare sector, and every year, I'm reminded why exposure to this sector is a must. Let the doctors and big pharma pay for your retirement.

HQH: I Am Getting A 9.5% Yield On My Last Buy

abrdn Healthcare Investors is a closed-ended fund focused on the global biotech & healthcare sector boasting a 10% dividend yield. The recent acquisition of Tekla Capital Management's funds by abrdn will not change the operations and strategies of HQH. HQH is currently trading at a 17.28% discount to NAV, indicating a potential 10% upside to historical averages, making it an attractive investment opportunity.

HQH: Discount To NAV Offers Attractive Entry Opportunity

abrdn Healthcare Investors fund (formerly Tekla Healthcare Investors) has been taken over by abrdn and renamed. However, day-to-day management remains the same. The HQH fund's heavy exposure to biotechnology has led to sub-par returns due to higher interest rates and poor equity risk appetites. Until those macro drivers change, I continue to recommend caution with the HQH fund.

HQH: New Name But Same Risky Bets On Biotech

BlackRock Energy and Resources Trust

I often get asked if you can retire just on dividends. And the answer is yes – yes, you can. Over 50% of Americans are not saving properly for retirement. The three-legged stool approach is dead. It's time to adapt.

Yes, You Can Retire On Dividends, 2 Big Yields Up To 11%

PHILADELPHIA, PA / ACCESSWIRE / October 27, 2023 / Effective close of business today, October 27, 2023, abrdn Inc. ("abrdn") assumed responsibility for the management of the four (4) former Tekla Capital Management LLC closed-end funds totaling $2.8bn in assets under management (AUM) as of October 26, 2023. As noted within the Funds' proxy statements and in connection with the change in investment adviser, each Fund amended its declaration of trust to change its name as detailed in the chart below effective after close of regular business on October 27, 2023.

abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes

BOSTON--(BUSINESS WIRE)--Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds). The Funds are: Tekla Healthcare Investors (HQH) Tekla Life Sciences Investors (HQL) Tekla Healthcare Opportunities Fund (THQ) Tekla World Healthcare Fund (THW) Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW) approved the proposal a.

Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling $2.8 bn in assets under management (AUM) as of October 26, 2023.

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Adams Diversified Equity Fund

Blackrock Health Sciences Trust

BlackRock Science and Technology Trust II

BlackRock Utilities Infrastructure & Power Opportunities Trust

ClearBridge Energy MLP Fund Inc

European Equity Fund

Templeton Emerging Markets Fund

Eaton Vance Tax Advantaged Global Dividend Opportunities Fund

Eaton Vance Tax-Advantaged Dividend Income Fund

Sprott Focus Trust

Gabelli Dividend & Income Trust

Gabelli Global Small and Mid Cap Value Trust

Eagle Capital Growth Fund Inc

Gabelli Healthcare & Wellness Trust

Morgan Stanley India Investment Fund Inc

Barings Participation Investors

Mexico Fund

PIMCO Energy and Tactical Credit Opportunities Fund

Income Portfolio - 38 CEFs Worth Exploring

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH) today announced at the Special Meetings of shareholders (“Special Meetings”) that the requisite vote had been attained for the proposal to approve the new investment advisory agreement with abrdn Inc. However, while the proposal has now been passed for both HQH and for Tekla Life Science Investors (HQL) at its meeting held on October 3rd, the new investment advisory agreement with abrdn Inc., and the related benefits that will accrue to.

Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds

BlackRock Resources & Commodities Strategy Trust

Seasonal changes can drive income higher in your portfolio. Two excellent picks for the end of the year. Caught a cold? Thank you for buying products that help yourself - and me!

Buy These 2 Magnificent Yields, Even If You Buy Nothing Else In October

Healthcare - we all need it, we all pay for it. You can receive outstanding income from this beaten-down sector. Stop just paying your medical bills; have those medical bills pay you.

2 Magnificent Passive Income Stocks, Up To 12% Yield

BOSTON--(BUSINESS WIRE)--On September 29, 2023, Tekla Healthcare Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of.

Tekla Healthcare Investors Paid Distribution

News for Tekla Healthcare Investors ETF (HQH)